Stent graft balloon catheter market seen topping $4.47 billion by 2030

The stent graft balloon catheter market is projected to rise from $2.77 billion in 2025 to $4.47 billion by 2030, driven by more cardiovascular disease, an aging population and wider use of minimally invasive vascular procedures. North America held the largest share in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Demand is rising for devices that help physicians treat aneurysms and other vascular blockages through minimally invasive procedures. - The market outlook signals more spending on endovascular repair, imaging-guided catheter tools and newer balloon catheter materials. - Growth in this segment tracks broader pressure on health systems from cardiovascular disease and aging populations.

What happened: - The Business Research Company published its Stent Graft Balloon Catheter Global Market Report 2026 on July 7, 2026. - The report values the market at $2.77 billion in 2025 and projects $3.05 billion in 2026. - The report forecasts the market will reach $4.47 billion by 2030, implying a 10.0% CAGR from 2026 to 2030. - The report also covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - Stent graft balloon catheters deliver and deploy a stent graft inside blood vessels. - The inflatable balloon expands and positions the stent graft at the target site. - The devices are used in minimally invasive endovascular procedures to strengthen weakened or diseased vessels. - The report links near-term growth to higher rates of cardiovascular and vascular disease, more older patients at risk of aneurysms and arterial conditions, wider use of minimally invasive surgery and continued catheter technology advances. - The forecast to 2030 is tied to demand for advanced endovascular repair techniques, more investment in vascular intervention technology, integration of imaging and navigation tools, growth in outpatient vascular care centers and development of more flexible balloon catheter materials. - Key product trends include low-profile balloon catheter systems, high-pressure stent graft balloon catheters for complex cases, broader use of drug-coated balloon catheters and precision-guided vascular intervention devices. - North America held the largest market share in 2025. - Asia-Pacific is expected to post the fastest growth in the coming years.

Between the lines: - The report points to a market shifting toward more precise, less invasive and more technology-enabled vascular procedures. - The strongest demand drivers are structural, not cyclical: aging populations, chronic disease burden and higher healthcare spending. - U.S. national health expenditure rose 7.2% to $5.3 trillion in 2024, equal to $15,474 per person and 18.0% of GDP, which supports continued adoption of advanced medical devices. - Cardiovascular disease deaths in the UK rose from 178 in 2022 to 185 in 2023, underscoring the ongoing clinical need behind the forecast. - The World Health Organization said in February 2025 that the global population aged 60 and above is increasing rapidly and is expected to outnumber younger cohorts in many regions by 2030.

What's next: - The market is expected to keep expanding as hospitals and outpatient centers adopt more advanced endovascular tools. - Asia-Pacific growth will likely be shaped by higher healthcare investment, population expansion and greater awareness of minimally invasive treatment options. - The report’s forecast suggests vendors will compete more on catheter performance, precision and compatibility with imaging and navigation systems.

The bottom line: - Stent graft balloon catheters are moving from a niche vascular tool to a growing part of the minimally invasive care stack, with demand supported by aging demographics and rising cardiovascular disease.